Plutonian Acquisition II, a blank check company targeting energy storage, telecom, and consumer sectors, announced terms for its IPO on Tuesday. The New York, NY-based company plans to raise $100 million by offering 10 million shares at a price of $10. Each...read more
EIR Biopharma, a preclinical biotech developing in-licensed therapies for eye diseases, filed on Tuesday with the SEC to raise up to $17 million in an initial public offering. The San Francisco, CA-based company plans to raise $17 million by offering 3.8...read more
Dynamix IV, a blank check company targeting the energy and power value chain, filed on Tuesday with the SEC to raise up to $175 million in an initial public offering. The company plans to raise $175 million by offering 17.5 million units at $10. Each unit...read more
SPAC Plutonian Acquisition II files for $100 million IPO, targeting energy storage, telecom, and consumer sectors
Plutonian Acquisition II, a blank check company targeting energy storage, telecom, and consumer sectors, announced terms for its IPO on Tuesday. The New York, NY-based company plans to raise $100 million by offering 10 million shares at a price of $10. Each...read more
Eye disease therapy developer EIR Biopharma files for a $17 million IPO
EIR Biopharma, a preclinical biotech developing in-licensed therapies for eye diseases, filed on Tuesday with the SEC to raise up to $17 million in an initial public offering. The San Francisco, CA-based company plans to raise $17 million by offering 3.8...read more
SPAC Dynamix IV files for a $175 million IPO, targeting energy and power
Dynamix IV, a blank check company targeting the energy and power value chain, filed on Tuesday with the SEC to raise up to $175 million in an initial public offering. The company plans to raise $175 million by offering 17.5 million units at $10. Each unit...read more